Aclaris Therapeutics, Inc. (ACRS) Insider Trading

Name: Aclaris Therapeutics, Inc. (ACRS) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 4, 2026): Kolbeck Roland Wilhelm (Chief Scientific Officer): Exercise/Conversion of 36,375 shares.

Get alerted when insiders trade ACRS

Email address

Loading company data...

Loading company details...